Literature DB >> 19643360

Anabolics and cardiomyopathy in a bodybuilder: case report and literature review.

Christoph Ahlgrim1, Maya Guglin.   

Abstract

BACKGROUND: Athletes use androgenic-anabolic steroids to increase strength and muscle mass. Several case reports suggest that it may lead to dilated cardiomyopathy. METHODS AND
RESULTS: We report a case of a 41-year-old bodybuilder with severe systolic dysfunction and Class IV heart failure despite maximal medical therapy. He used anabolic steroids and insulin growth factor, and did not have any other risk factors for cardiomyopathy. We briefly review the literature and summarize other reported cases with similar scenarios. In most of them cardiomyopathy was at least partially reversible after discontinuation of anabolics.
CONCLUSIONS: Abuse of anabolic steroids may be an uncommon cause of cardiomyopathy in young and otherwise healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643360     DOI: 10.1016/j.cardfail.2008.12.014

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  17 in total

Review 1.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

3.  Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population.

Authors:  Richard D Rothman; Rory B Weiner; Harrison Pope; Gen Kanayama; Adolph M Hutter; Michael A Fifer; G William Dec; Aaron L Baggish
Journal:  BMJ Case Rep       Date:  2011-08-17

Review 4.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 5.  Anabolic steroids and cardiovascular risk.

Authors:  Peter Angell; Neil Chester; Danny Green; John Somauroo; Greg Whyte; Keith George
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

6.  Building Body With Anabolics Is Weakening the Heart: Anabolic Steroid Induced Cardiomyopathy.

Authors:  Pradnya Brijmohan Bhattad; Mazen Roumia
Journal:  Cureus       Date:  2022-07-05

7.  Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuse.

Authors:  Onyedika J Ilonze; Chioma O Enyi; Chibuzo C Ilonze
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-03-17

8.  Performance-Enhancing Substance Use and Sexual Risk Behaviors among U.S. Men: Results from a Prospective Cohort Study.

Authors:  Kyle T Ganson; Dylan B Jackson; Alexander Testa; Pamela M Murnane; Jason M Nagata
Journal:  J Sex Res       Date:  2021-12-03

9.  Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon.

Authors:  Ernst R Schwarz; Anita Phan; Robert D Willix
Journal:  J Geriatr Cardiol       Date:  2011-03       Impact factor: 3.327

Review 10.  Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis.

Authors:  Dominic Sagoe; Jim McVeigh; Astrid Bjørnebekk; Marie-Stella Essilfie; Cecilie Schou Andreassen; Ståle Pallesen
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.